CN104069384A - Traditional Chinese medicine powder for treating type II diabetes mellitus qi deficiency and blood stasis - Google Patents
Traditional Chinese medicine powder for treating type II diabetes mellitus qi deficiency and blood stasis Download PDFInfo
- Publication number
- CN104069384A CN104069384A CN201410349771.1A CN201410349771A CN104069384A CN 104069384 A CN104069384 A CN 104069384A CN 201410349771 A CN201410349771 A CN 201410349771A CN 104069384 A CN104069384 A CN 104069384A
- Authority
- CN
- China
- Prior art keywords
- diabetes mellitus
- chinese medicine
- traditional chinese
- hyperglycemia
- thirst
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention relates to traditional Chinese medicine powder for treating type II diabetes mellitus of qi deficiency and blood stasis, and can effectively solve the medicine administration problem of preventing and treating hyperglycemia. The technical scheme for solving the problem is that the traditional Chinese medicine powder is formed by grinding and uniformly mixing the following components by weight: 25-35 g of corn silk, 25-35 g of kudzuvine root, 25-35 g of soybean meals, 18-22 g of Flos Sophorae, 9-11 g of mongolian dandelion herb, 50-70 g of yam, and 50-70 g of oat meal; all components support one another, and the remarkable function of reducing hyperglycemia is obtained; the traditional Chinese medicine powder can be used for effectively preventing and treating diabetes mellitus caused by hyperglycemia; as one of the clinical syndromes of hyperglycemia is thirst and high consumption of water, the traditional Chinese medicine powder can be effectively used for preventing thirst and excess water consumption for reducing hyperglycemia; therefore, the traditional Chinese medicine powder is also called thirst relieving and restoring powder, is an innovation of hypoglycemic agent, and has huge economical and social benefits.
Description
Technical field
The present invention relates to Chinese medicine, particularly a kind of Chinese powder medicine (claiming to quench one's thirst again recovery powder) for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus.
Background technology
Hyperglycemia is often to send out disease common, is to take the high metabolic disease as feature of blood glucose.Hyperglycemia be due to defect of insulin secretion or its biological agent impaired, or both have concurrently and cause.Diabetes are long-standing hyperglycemia, cause various tissues, particularly eye, kidney, heart, blood vessel, neural chronic lesion, dysfunction, when hyperglycemia develops into diabetes, just be difficult to cure, people's healthy and life security in serious threat, once therefore there is hyperglycemia, will treat in time, reduce blood glucose, that is to say, the key of preventing and treating diabetes is how effectively to prevent hyperglycemia or reduces blood glucose, so-called Qi deficiency blood stasis type type 2 diabetes mellitus is again non-insulin-dependent diabetes mellitus, the genus traditional Chinese medical science category of " quenching one's thirst ".Primary disease can betide any age, is especially more common in 50 years old above middle-aged and elderly people.Along with the change of China's aged tendency of population and life style, prevalence rises year by year.Therefore how to prevent and treat the healthy and life security that blood stasis due to qi deficiency type 2 diabetes mellitus is directly connected to people, though existing, there is the multiple medicine of preventing and treating hyperglycemia, but actually rare for preventing and treating Qi deficiency blood stasis type type 2 diabetes mellitus, though the existing appearance that has some medicines, but for various reasons, its effect is also unsatisfactory, and Chinese medicine has the effect unique of the various difficult disease for the treatment of, therefore, how to develop a kind ofly new there is blood sugar reducing function, for preventing and treating the Chinese medicine of Qi deficiency blood stasis type type 2 diabetes mellitus, be the technical problem be concerned about in the industry.
Summary of the invention
For above-mentioned situation, for overcoming the defect of prior art, the present invention's object is just to provide a kind of Chinese powder medicine (claiming to quench one's thirst again recovery powder) for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus, can effectively solve the control medication problem of hyperglycemia.
The technical scheme that the present invention solves is, the Chinese powder medicine of this blood sugar reducing function is pulverized and mixed evenly and is formed by Stigma Maydis 25-35g, Radix Puerariae 25-35g, soybean residue 25-35g, Flos Sophorae 18-22g, Herba Taraxaci 9-11g, Rhizoma Dioscoreae 50-70g and the oatmeal 50-70g of following weighing scale.
Mutual support between said components, the function with significant reduction blood glucose, be effective to prevent and treat the diabetes that hyperglycemia causes, due to after hyperglycemia symptom occurs, one of its clinical disease be exactly thirsty, drink water many, Chinese powder medicine of the present invention can be effective to prevent thirsty and too much inflow, reduce blood glucose, therefore, this Chinese powder medicine claims again the recovery powder of quenching one's thirst, be the innovation on hypoglycemic medicine, have huge economic and social benefit.
The specific embodiment
Below in conjunction with embodiment, the specific embodiment of the present invention is elaborated.
The present invention, in concrete enforcement, can be provided by following examples.
Embodiment 1
The present invention is in concrete enforcement, and the Chinese powder medicine of this blood sugar reducing function is pulverized and mixed evenly and is formed by Stigma Maydis 30g, Radix Puerariae 30g, soybean residue 30g, Flos Sophorae 20g, Herba Taraxaci 10g, Rhizoma Dioscoreae 60g and the oatmeal 60g of following weighing scale.
Embodiment 2
The Chinese powder medicine of blood sugar reducing function of the present invention is also pulverized and mixed evenly and is formed by Stigma Maydis 25g, Radix Puerariae 35g, soybean residue 25g, Flos Sophorae 22g, Herba Taraxaci 9g, Rhizoma Dioscoreae 70g and the oatmeal 50g of following weighing scale.
Embodiment 3
The Chinese powder medicine of blood sugar reducing function of the present invention is also pulverized and mixed evenly and is formed by Stigma Maydis 35g, Radix Puerariae 25g, soybean residue 35g, Flos Sophorae 18g, Herba Taraxaci 11g, Rhizoma Dioscoreae 50g and the oatmeal 70g of following weighing scale.
Embodiment 4
The Chinese powder medicine of blood sugar reducing function of the present invention is also pulverized and mixed evenly and is formed by Stigma Maydis 28-32g, Radix Puerariae 28-32g, soybean residue 28-32g, Flos Sophorae 19-21g, Herba Taraxaci 9.5-10.5g, Rhizoma Dioscoreae 55-65g and the oatmeal 55-65g of following weighing scale.
Each component of the present invention supports mutually to have reduction blood glucose, and the effect of quenching one's thirst is effective to prevent and treat Qi deficiency blood stasis type type 2 diabetes mellitus, and has obtained fully proving through animal experiment and clinical trial, and related tests data is as follows:
One, animal experiment
1, the recovery powder of quenching one's thirst causes the impact of mice hyperglycemia model on epinephrine
1.1 trial drug
Normal saline, Zhengzhou Yonghe Pharmaceutical Co; Adrenalin hydrochloride injection, Tianjin Jin Yao aminoacid company limited; Concentrated sulphuric acid, Luoyang Hao Hua chemical reagent company limited; Metformin hydrochloride, Shanghai Pharmaceutical Group company limited letter friendship pharmacy head factory; Glucose kit, Bioengineering Research Institute is built up in Nanjing; Liver glycogen test kit, Bioengineering Research Institute is built up in Nanjing; The present invention's recovery powder of quenching one's thirst.
1.2 instrument
Electronic balance, the inscription calibration equipment company limited of weighing records in Yuyao; Electronic balance, Shanghai Jingtian Electronic Instrument Co., Ltd.; UV-2000 ultraviolet-uisible spectrophotometer, Shanghai Techcomp Instrument Ltd. produces; Electric-heated thermostatic water bath, Shanghai Yiheng Scientific Instruments Co., Ltd; TDL-40B centrifuge, Anting Scientific Instrument Factory, Shanghai; 101 type electric drying oven with forced convections, Beijing is bright Medical Instruments factory forever; Micropipettor, Qiujing Bio-Chemical Reagent Instrument Co., Ltd., Shanghai.
1.3 laboratory animal
Kunming mouse, male, body weight: 18～21g, is provided by Hubei Province's Experimental Animal Center, the quality certification number 0003728.1.4 experimental technique
Get 60 of male mices, animal is divided into 5 groups at random, 12 every group, normally raise after 3 days and start to test; Blank group, model group, the normal feedstuff of metformin group feed; Large and small dosage quench one's thirst the feedstuff that recovery powder group feed is processed into by the recovery powder of quenching one's thirst (heavy dose of group of recovery powder of quenching one's thirst account for normal feedstuff 50%, small dose group quench one's thirst recovery powder account for normal feedstuff 25%).Metformin group gavages metformin suspension (200mg/kg, 10mg/ml, 0.2ml/10g), and other each groups all gavage the normal saline of same volume.Administration every day 1 time, feed as stated above, continuous 7 days.After the 7th day fasting 6h, administration 60min, except blank group, the every group of rapid lumbar injection epinephrine of mice 240ug/kg, the normal saline of blank group injection same volume, gets blood respectively at Injection of Adrenaline 30min, 60min, separation of serum; Survey and respectively manage OD value, and calculate blood glucose value (by the operation of test kit illustration method) according to OD value.Put to death after mice, take liver 75mg, survey and respectively manage OD value, and calculate glycogen initial value (by the operation of test kit illustration method) according to OD value.The results are shown in Table 1.
1.5 result of the test
Table 1 quench one's thirst recovery powder on epinephrine cause mice hyperglycemia model blood glucose and hepatic glycogen impact (
n=12)
*: represent to compare P<0.05 with model group; *: represent to compare P<0.01 with model group
As can be seen from the above table, with blank group ratio, model group 30min, 60min blood sugar level significantly raise (P<0.01), hepatic glycogen level significantly reduces (P<0.01), illustrate and make the success of hyperglycemia mould.Compare with model group, heavy dose of group recovery powder group of quenching one's thirst can significantly reduce epinephrine induced mice hyperglycemia model blood sugar level (P<0.01) at 30min, 60min, significantly promotes synthetic (P<0.01) of hepatic glycogen; The small dose group recovery powder group of quenching one's thirst can star reduce epinephrine induced mice hyperglycemia model blood sugar level (P<0.01) at 60min; Metformin group can significantly reduce epinephrine induced mice hyperglycemia model blood sugar level (P<0.01) at 30min, 60min, and star promotes synthetic (P<0.05) of hepatic glycogen; .Point out the recovery powder of quenching one's thirst to have blood sugar lowering and promote hepatic glycogen anabolic effect.
2, alloxan is caused the impact of mice hyperglycemia model
2.1 reagent
Alloxan, sigma company; Normal saline, Zhengzhou Yonghe Pharmaceutical Co; Adrenalin hydrochloride injection, Tianjin Jin Yao aminoacid company limited; Concentrated sulphuric acid, Luoyang Hao Hua chemical reagent company limited; Metformin hydrochloride, Shanghai Pharmaceutical Group company limited letter friendship pharmacy head factory; Glucose kit, Bioengineering Research Institute is built up in Nanjing; Liver glycogen test kit, Bioengineering Research Institute is built up in Nanjing; The present invention's recovery powder of quenching one's thirst.
2.2 instrument
Electronic balance, the inscription calibration equipment company limited of weighing records in Yuyao; Electronic balance, Shanghai Jingtian Electronic Instrument Co., Ltd.; UV-2000 ultraviolet-uisible spectrophotometer, Shanghai Techcomp Instrument Ltd. produces; ; Electric-heated thermostatic water bath, Shanghai Yiheng Scientific Instruments Co., Ltd; TDL-40B centrifuge, Anting Scientific Instrument Factory, Shanghai; 101 type electric drying oven with forced convections, Beijing is bright Medical Instruments factory forever; Micropipettor, Qiujing Bio-Chemical Reagent Instrument Co., Ltd., Shanghai.
2.3 laboratory animal
Kunming mouse, male, body weight: 18～21g, is provided the quality certification number: 812077 by Hebei province's Experimental Animal Center
2.4 experimental technique
Get 60 of male mices, animal is divided into 5 groups at random, 12 every group, normally raise after 3 days and start to test; Blank group, model group, the normal feedstuff of metformin group feed; Large and small dosage quench one's thirst the feedstuff that recovery powder group feed is processed into by the recovery powder of quenching one's thirst (heavy dose of group of recovery powder of quenching one's thirst account for normal feedstuff 50%, small dose group quench one's thirst recovery powder account for normal feedstuff 25%).Metformin group gavages metformin suspension (200mg/kg, 10mg/ml, 0.2ml/10g), and other each groups all gavage the normal saline of same volume.Administration every day 1 time, feed as stated above, continuous 7 days.After the 7th day fasting 6h, administration 60min, except blank group, every group of mouse tail vein injection (60mg/kg; 12mg/ml; 0.05ml/10g) the alloxan solution of new preparation.After injection 72h (after 12h in a manner described feed, water is can't help in 66h fasting), fasting 6h gets blood, and separation of serum is surveyed and respectively managed OD value, and calculates blood glucose value (operating by test kit illustration method) according to OD value; Put to death after mice, take liver 75mg, survey and respectively manage OD value, and calculate glycogen initial value (by the operation of test kit illustration method) according to OD value; Get pancreas, 10% formalin solution is fixed, and does pathological section.The results are shown in Table 2,3.
2.5 result
Table 2 quench one's thirst recovery powder on alloxan cause mice hyperglycemia model blood glucose and hepatic glycogen impact (
n=12)
*: represent to compare P<0.05 with model group; *: represent to compare P<0.01 with model group
As can be seen from the above table, with blank group ratio, model group blood sugar level significantly raises (P<0.01), hepatic glycogen level significantly reduces (P<0.01), illustrates and makes the success of hyperglycemia mould.Compare with model group, quench one's thirst recovery powder group and metformin group of large and small dosage group all can significantly reduce the blood sugar level (P<0.01) of alloxan induced mice hyperglycemia model.Compare with model group, heavy dose of group of quench one's thirst recovery powder group and metformin group all can significantly promote the hepatic glycogen synthetic (P<0.01) of alloxan induced mice hyperglycemia model.Point out the recovery powder of quenching one's thirst to have blood sugar lowering and promote hepatic glycogen anabolic effect.
Each organizes pancreas tissue morphology situation: blank group Mice Islet Cells volume is large, and endochylema is abundant, and nucleus is sparse; Intercalary tubule cell and born of the same parents' core cell are normal.The obvious atrophy of model group Mice Islet Cells, endochylema reduces, and nucleus is intensive; Intercalary tubule cell and born of the same parents' core cell are normal.With model group mice ratio, metformin group Mice Islet Cells volume increases to some extent, and endochylema is abundanter, but nucleus comparatively dense still; Intercalary tubule cell and born of the same parents' core cell are normal.The heavy dose recovery powder group Mice Islet Cells volume of quenching one's thirst obviously increases, and endochylema is abundant, and nucleus is more sparse; Intercalary tubule cell and born of the same parents' core cell are normal.The heavy dose recovery powder group Mice Islet Cells volume of quenching one's thirst is little, and endochylema is abundant, nucleus comparatively dense; Intercalary tubule cell and born of the same parents' core cell are normal.
Table 3 recovery powder of quenching one's thirst causes the impact of mice hyperglycemia model pancreas tissue morphology on alloxan
" – ": islet cells volume is large, endochylema is abundant, and nucleus is sparse normal; "+": atrophy that islet cells is slight, endochylema reduces to some extent, and nucleus is more sparse; " ++ ": the atrophy of islet cells part, endochylema reduces, parts of fine karyon comparatively dense; " +++ ": the obvious atrophy of islet cells, endochylema obviously reduces, and nucleus is intensive.
From upper table, can find out, through Ridit check, with blank group ratio, there is remarkable pathological change (P<0.01) in model group pancreas.With model group ratio, the heavy dose of group of damage (P<0.05) that quench one's thirst recovery powder group and metformin group all can star alleviate alloxan induced mice hyperglycemia model pancreas.
The present invention of above-mentioned animal experiment proof has good blood sugar reducing function, and has obtained satisfied useful technique effect through clinical trial.
Two, clinical trial data
1, select the standard of case
Qi deficiency blood stasis type type 2 diabetes mellitus is again non-insulin-dependent diabetes mellitus, belongs to the traditional Chinese medical science category of " quenching one's thirst ".Primary disease can betide any age, how after 35～40 years old, to fall ill, and accounts for diabetics more than 90%, is especially more common in 50 years old above middle-aged and elderly people.Clinical manifestation is that blood glucose is high, thirsty, the ability that produces insulin in type 2 diabetes mellitus patient body not completely loses, in some patient bodies, insulin even produces too much, but the action effect of insulin is poor, therefore the insulin in patient body is a kind of relative shortage, otherwise disconnected oral drugs stimulate the secretion of insulin in body.All have an above-mentioned symptom, all as the standard of selecting case.
2, diagnostic criteria
Western medicine diagnose adopts WHO (1999) standard, and the patient who meets following standard includes this test in: 1. 36～70 years old age, men and women all can; 2. Body Mass Index (BMI) 19～32kg/m
2; 3. before this on-test, used sulfonylurea, biguanides, alpha-glucosidase inhibitor or Nateglinide, the Repaglinide in treatment of patients of consistent dose, stable disease at least 1 month, keeps former constant with types of drugs and dosage with being intended to duration of test; 4. fasting glucose (FPG) 7.0～13.0mmol/L, in 2 weeks still within the scope of this and changing value≤2.0mmol/L; 5. blood pressure≤160/95mmHg, has history of hypertension person to use depressor dosage to stablize more than 1 month; 6. the women of child-bearing age take effective contraceptives, and pregnancy tests are negative.
Tcm diagnosis is worked out with reference to the standard of diabetes in < < new Chinese medicine guideline of clinical investigations > >, have especially that blood glucose is high, thirsty, water requirement is large, be diagnosed as Qi deficiency blood stasis type type 2 diabetes mellitus, and give Drug therapy of the present invention.
3, therapeutic scheme
The present invention adopts oral, and with early, middle and late the servicing once of having a dinner, each consumption 70-100g, can suitably adjust with patient body situation, within 12 weeks, is a course for the treatment of, after the course for the treatment of, adds up curative effect.
4, efficacy assessment standard
MAIN OUTCOME MEASURES is fasting glucose, detects respectively before patient's dietetic therapy 2,6,12 weeks fasting glucose after fasting glucose and dietetic therapy, does curative effect comparison.
Record the forward and backward patient's cardinal symptom of dietetic therapy: thirsty polydipsia, easy hungry polyphagia, frequent micturition, constipation, vexed insomnia, weak, red tongue with yellow fur, wiry and frequent pulse or stringy and rolling pulse number.Scoring criteria is with reference to < < new Chinese medicine guideline of clinical investigations > > related content, according to symptom and sign without, light, in, heavy, remember respectively 0,2,4,6 minute.
Tcm symptom criterion of therapeutical effect is drafted with reference to < < new Chinese medicine guideline of clinical investigations > >.Effective: symptom integral reduces >=30%, or recover normal.Invalid: not reach above-mentioned standard.
5, statistical procedures
By therapeutic scheme of the present invention, warp is to type 2 diabetes mellitus case 40 examples, all from hospital outpatient.Man's 23 examples, female's 17 examples, at 36～70 years old age, average 58 years old, average course of disease 5.5 years, took Chinese powder medicine of the present invention (recovery powder of quenching one's thirst), after 12 weeks, adds up curative effect, adopted SPSS13.0 statistical software.Data with mean ± standard deviation (
) represent, measurement data is checked with t, ranked data rank test.Using the standard of α=0.05 as significant difference.Statistical disposition result is as follows:
Type 2 diabetes mellitus patient dietary after dietetic therapy, uncomfortable sensation obviously alleviates, and blood glucose fluctuation situation is than reduce in the past, and fasting glucose index all has clear improvement (in Table 1) before compared with dietetic therapy, every symptom and sign all take a favorable turn (in Table 2,3).
The forward and backward fasting glucose index variation of table 1 dietetic therapy comparison (
)
Note: * represent with dietetic therapy before P<0.05 relatively.
The forward and backward cardinal symptom of table 2 dietetic therapy, somatic feature score comparison (
)
12 weeks tcm syndrome curative effects comparison after table 3 dietetic therapy
In above-mentioned test, without finding that there is any untoward reaction, show to take safety, effective, in the user of institute 40 examples, all obtained useful technique effect in various degree, in edible Chinese powder medicine 40 examples of the present invention, be that effective percentage reaches 100%, getting well of effect formerly do not expected.
5, conclusion
Type 2 diabetes mellitus is wasting diseases, if control badly, its complication is as serious threat human healths such as blind, nephropathy, neuropathy, cardio cerebrovascular affections.Doctor trained in Western medicine is main mainly with anti symptom treatment such as blood sugar lowering, blood pressure lowering, but a large amount of Western medicine of long-term taking are unfavorable to health.
For improving patient's health level and quality of life, the pathogenic characteristic for Qi deficiency blood stasis type card, by the dialectical principle of executing food, on the basis of doctor trained in Western medicine conventional therapy, gives diabetes diet therapy nutrient flour special (recovery powder of quenching one's thirst) and treats.Observe after treatment, Fasting Glucose obviously reduces (P<0.05), and various symptoms are obviously improved.Prompting can alleviate islets of langerhans burden by this nutritive powder (recovery powder of quenching one's thirst) dietetic therapy, there is QI invigorating YIN nourishing, spleen benefiting and strengthen kidney, quench one's thirst, reduce blood glucose to improve symptom, safe and reliable, taking convenience, cost is low, easily produces, be very beneficial for the control to diabetes, be beneficial to the healthy of patient, have very strong use value, economic and social benefit is huge.
Claims (6)
1. a Chinese powder medicine for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus, it is characterized in that, by Stigma Maydis 25-35g, Radix Puerariae 25-35g, soybean residue 25-35g, Flos Sophorae 18-22g, Herba Taraxaci 9-11g, Rhizoma Dioscoreae 50-70g and the oatmeal 50-70g of following weighing scale, be pulverized and mixed evenly and form.
2. the Chinese powder medicine for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus according to claim 1, it is characterized in that, by Stigma Maydis 30g, Radix Puerariae 30g, soybean residue 30g, Flos Sophorae 20g, Herba Taraxaci 10g, Rhizoma Dioscoreae 60g and the oatmeal 60g of following weighing scale, be pulverized and mixed evenly and form.
3. the Chinese powder medicine for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus according to claim 1, it is characterized in that, by Stigma Maydis 25g, Radix Puerariae 35g, soybean residue 25g, Flos Sophorae 22g, Herba Taraxaci 9g, Rhizoma Dioscoreae 70g and the oatmeal 50g of following weighing scale, be pulverized and mixed evenly and form.
4. the Chinese powder medicine for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus according to claim 1, it is characterized in that, by Stigma Maydis 35g, Radix Puerariae 25g, soybean residue 35g, Flos Sophorae 18g, Herba Taraxaci 11g, Rhizoma Dioscoreae 50g and the oatmeal 70g of following weighing scale, be pulverized and mixed evenly and form.
5. the Chinese powder medicine for the treatment of Qi deficiency blood stasis type type 2 diabetes mellitus according to claim 1, it is characterized in that, by Stigma Maydis 28-32g, Radix Puerariae 28-32g, soybean residue 28-32g, Flos Sophorae 19-21g, Herba Taraxaci 9.5-10.5g, Rhizoma Dioscoreae 55-65g and the oatmeal 55-65g of following weighing scale, be pulverized and mixed evenly and form.
6. the application of the Chinese powder medicine of the treatment Qi deficiency blood stasis type type 2 diabetes mellitus described in claim 1 or 2-5 any one in preparation control Qi deficiency blood stasis type type 2 diabetes mellitus medicine.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410349771.1A CN104069384A (en) | 2014-07-22 | 2014-07-22 | Traditional Chinese medicine powder for treating type II diabetes mellitus qi deficiency and blood stasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410349771.1A CN104069384A (en) | 2014-07-22 | 2014-07-22 | Traditional Chinese medicine powder for treating type II diabetes mellitus qi deficiency and blood stasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104069384A true CN104069384A (en) | 2014-10-01 |
Family
ID=51591250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410349771.1A Pending CN104069384A (en) | 2014-07-22 | 2014-07-22 | Traditional Chinese medicine powder for treating type II diabetes mellitus qi deficiency and blood stasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104069384A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108143952A (en) * | 2017-11-17 | 2018-06-12 | 张国发 | A kind of preparation method of plant hypoglycemic agent |
| CN108576542A (en) * | 2018-05-24 | 2018-09-28 | 杨进成 | A kind of mixed type draft solid beverage and preparation method thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494997A (en) * | 2013-10-18 | 2014-01-08 | 河南中医学院 | Traditional Chinese sophora flower medicine for treating hyperglycemia and diabetes |
-
2014
- 2014-07-22 CN CN201410349771.1A patent/CN104069384A/en active Pending
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103494997A (en) * | 2013-10-18 | 2014-01-08 | 河南中医学院 | Traditional Chinese sophora flower medicine for treating hyperglycemia and diabetes |
Non-Patent Citations (2)
| Title |
|---|
| 李淑君: "尚品洁主任医师治疗糖尿病经验", 《中医药导报》 * |
| 高志雄: "《运动+饮食+按摩：自我调养糖尿病》", 31 July 2013 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108143952A (en) * | 2017-11-17 | 2018-06-12 | 张国发 | A kind of preparation method of plant hypoglycemic agent |
| CN108576542A (en) * | 2018-05-24 | 2018-09-28 | 杨进成 | A kind of mixed type draft solid beverage and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103405655B (en) | Chinese medicine composition of a kind of blood sugar lowering and preparation method thereof | |
| CN103417846B (en) | Chinese medicine composition of a kind of blood sugar lowering and preparation method thereof | |
| CN111643586A (en) | Traditional Chinese medicine composition for invigorating spleen and activating collaterals and application thereof | |
| CN100493572C (en) | Composition of medication for treating diabetes | |
| CN102861201B (en) | Medicine composition for treating diabetes and preparation method thereof | |
| CN102579803B (en) | Medicine for treating post-chemotherapy leucopenia and preparation method thereof | |
| CN103623296A (en) | Preparation method of extract of traditional Chinese medicine with functions of regulating qi, relieving pain, invigorating stomach and promoting digestion | |
| CN104491342A (en) | Medicament for treating diabetes and preparation method thereof | |
| CN100586465C (en) | Chinese medicine composition for treating melancholia and preparation method thereof | |
| CN105943651B (en) | A kind of Chinese medicine composition that treating premature ovarian failure and its application | |
| CN103705796B (en) | A kind of pharmaceutical composition for the treatment of diarrhoea and preparation method thereof | |
| CN104069384A (en) | Traditional Chinese medicine powder for treating type II diabetes mellitus qi deficiency and blood stasis | |
| CN103223087A (en) | Food therapy formula for treating diabetes mellitus | |
| CN105596735A (en) | Medicine composition for treating diabetes mellitus | |
| CN103550671B (en) | The application of precious imperial refreshment medicine compositions in preparation treatment diabetic peripheral neuropathy medicine | |
| CN105456734A (en) | Traditional Chinese medicine for treating diabetes | |
| CN102552677B (en) | Coptis chinensis and radix rehmanniae Anxiao capsule and preparation method thereof | |
| CN102335362B (en) | Traditional Chinese medicine for treating insulin resistance of type 2 diabetes | |
| CN104606536A (en) | Traditional Chinese medicine composition with anti-depression function and application of traditional Chinese medicine composition | |
| CN103948666B (en) | Preparation method of Tibetan medicine for treating diabetes | |
| CN103230552A (en) | Traditional Chinese medicine for treating diabetes mellitus | |
| CN110279824A (en) | A kind of Chinese medicine composition and its application for treating Parkinson's disease | |
| CN104784472A (en) | Traditional Chinese medicine composition for decreasing blood sugar to treat diabetes | |
| CN103263595A (en) | Traditional Chinese medicine composition for treating diabetes | |
| CN102949459A (en) | Medicinal composition for reducing blood sugar and capsule preparation method of the medicinal composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20141001 |